Yahoo

UConn gene discovery moves closer to treating neuromuscular disease, holds promise for weight loss

A UConn professor and researcher who 28 years ago discovered a gene for a protein that limits human muscle growth is closer than ever to having that work play a significant role in treating those with ...
Seeking Alpha

PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment

KAWASAKI, Japan--(BUSINESS WIRE)-- PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) today announced the ...
Seeking Alpha

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

- Data support that Scholar Rock’s unique approach to selective myostatin inhibition could improve body composition in people living with obesity and on an existing background treatment - Scholar Rock ...
BioWorld

Peptidream’s oral myostatin inhibitors show lean body mass preservation in obesity model

Peptidream Inc. has released promising results from preclinical testing of its oral myostatin inhibitors, administered in combination with semaglutide, in a mouse model of obesity.
FierceBiotech

PeptiDream's macrocyclic peptides preserve muscle mass in mice given semaglutide

PeptiDream, the Japanese biopharma with a penchant for deal-making, has a new bargaining chip in its hand in the red-hot obesity space. The firm’s oral macrocyclic peptides preserved lean muscle mass ...